Decreased density of CD3+ tumor-infiltrating lymphocytes during gastric cancer progression

CD4/CD8 co-expression shows independent prognostic impact in resected non-small cell lung cancer patients treated with adjuvant radiotherapy

(2013) Sigurd M. Hald et al.   LUNG CANCER

B7-H4 expression associates with cancer progression and predicts patient’s survival in human esophageal squamous cell carcinoma

(2011) Lu-jun Chen et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Japanese gastric cancer treatment guidelines 2010 (ver. 3)

(2011)   Gastric Cancer

Clinical Significance of the B7-H4 Coregulatory Molecule as a Novel Prognostic Marker in Gastric Cancer

(2011) Takaaki Arigami et al.   WORLD JOURNAL OF SURGERY

Clinical impact of tumor-infiltrating lymphocytes for survival in stage II colon cancer

(2010) Won-Suk Lee et al.   CANCER

Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma

(2010) Jing Sun et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Tumour-infiltrating lymphocytes and survival in patients with adenocarcinoma of the oesophagus

(2010) U. Zingg et al.   EJSO

Intraepithelial CD8-positive T lymphocytes predict survival for patients with serous stage III ovarian carcinomas: relevance of clonal selection of T lymphocytes

(2009) M Stumpf et al.   BRITISH JOURNAL OF CANCER

CD3+ cells at the invasive margin of deeply invading (pT3–T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study

(2009) Luigi Laghi et al.   LANCET ONCOLOGY

Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer

(2008) H E Lee et al.   BRITISH JOURNAL OF CANCER

Treatment strategy after non-curative endoscopic resection of early gastric cancer

(2008) I. Oda et al.   BRITISH JOURNAL OF SURGERY

Validation of staging systems for gastric cancer

(2008) Keishi Yamashita et al.   Gastric Cancer

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial

(2008) Wasaburo Koizumi et al.   LANCET ONCOLOGY